RÉSUMÉ
<p><b>OBJECTIVE</b>To investigate whether administrating Abnormal Savda Munziq (ASMq), a traditional Uighur herbal preparation used for the prevention or treatment of diseases, affects hypertrophic scar (HTS) formation by using an established rabbit ear model.</p><p><b>METHODS</b>The HTS rabbit model was created by circular fullthickness skin excisions on both ears of rabbits. Twenty rabbits were randomized into four groups, with 5 rabbits and 60 wounds in each group. Group A was the control group, treated with normal saline daily. Groups B, C, and D were the treatment groups at three different doses of ASMq (400, 800, and 1200 mg/kg body weight, respectively, daily, by gastrogavage). Twenty wounds were randomly chosen from each group on the 40th day after treatment and specimen were examined. Scar elevation index (SEI) was analyzed with histological assessment, and ultrastructure analysis was analyzed with a transmission electron microscopy.</p><p><b>RESULTS</b>Groups B, C, and D demonstrated significant reductions in SEI as compared with the control group at 35.9% (P=0.0212), 48.2% (P=0.0108), and 52.7% (P=0.0103), respectively in a dose-response manner. SEI was lowered in Group D compared with Group B with a significant difference (P=0.015). However, there were no significant differences between Groups B and C, or between Groups C and D. Histological analysis showed that highdose ASMq (1200 mg/kg) could enhance the softening of HTS of rabbit ears and increase the compliance as shown in general. Ultrastructure analysis showed that with increased ASMq dose, the fibroblasts, pro-collagen, collagen, endoplasmic reticulum and ribosomes were reduced gradually.</p><p><b>CONCLUSIONS</b>Orally administered ASMq significantly reduces the severity of HTS in the rabbit ear model. The findings of this study may have clinical implications on the management of human HTS.</p>
Sujet(s)
Animaux , Femelle , Lapins , Cicatrice hypertrophique , Traitement médicamenteux , Anatomopathologie , Modèles animaux de maladie humaine , Médicaments issus de plantes chinoises , Pharmacologie , Utilisations thérapeutiques , Oreille , Anatomopathologie , Extraits de plantes , Pharmacologie , Utilisations thérapeutiques , Cicatrisation de plaieRÉSUMÉ
<p><b>OBJECTIVE</b>To evaluate in vitro effect of abnormal savda munziq (ASMq) on the proliferation and apoptosis of human hypertrophic scar fibroblasts (HSFs).</p><p><b>METHODS</b>HSFs were divided into six groups to receive different treatments as group A (blank control group), group B-E (ASMq in different concentration), and group F(5-Fu). Each group contains six specimens. The HSFs were cultured in vitro. After culture for 48 hours, the CCK8 test and flow cytometry methods were used to detect the proliferation, cell cycle and apoptosis.</p><p><b>RESULTS</b>The proliferation of HSFs in the B, C, D and E groups was inhibited at G2/M period, while it was inhibited at G0/S period in group F (P < 0.05). The inhibition effect of ASMq (0.1-1.0 mg/ml) on the fibroblasts enhanced in a concentration-dependent manner. Flow cytometry analysis with annexin V-FITC and PI staining confirmed the apoptotic. When HSFs were exposed to ASMq at 1.0 mg/ml (group E) for 48 h, the percentage of apoptotic cells increased to (43.7 +/- 2.58)%, which was significantly higher than that of blank control group (2.2 +/- 0.59)%. The induced apoptosis effect was also increased in a concentration-dependent manner.</p><p><b>CONCLUSION</b>ASMq has a inhibitory effect on the proliferation and an enhancement effect on the apoptosis of fibroblast. ASMq could be used as an effective drug for treatment of hypertrophic scar.</p>
Sujet(s)
Humains , Apoptose , Cycle cellulaire , Physiologie , Division cellulaire , Prolifération cellulaire , Cellules cultivées , Cicatrice hypertrophique , Anatomopathologie , Fibroblastes , Biologie cellulaire , Cytométrie en flux , Techniques in vitro , Médecine traditionnelle d'Asie orientaleRÉSUMÉ
<p><b>OBJECTIVE</b>To study the expression of the mRNAs of transient receptor potential (TRP) gene subfamily TRPV and TRPM in rat testes.</p><p><b>METHODS</b>Normal SD rat testes were collected and the expression of TRPV and TRPM mRNAs were detected by routine RT-PCR.</p><p><b>RESULTS</b>The TRPV4, TRPV5, TRPV6, TRPM3, TRPM4 and TRPM8 mRNAs were detected in the rat testes, but the other members of TRPV and TRPM family were not detected.</p><p><b>CONCLUSIONS</b>TRPV4, TRPV5, TRPV6, TRPM3, TRPM4 and TRPM8 are expressed in rat testes. This finding provides the basis for exploring the functions of TRPV and TRPM in the testes and the relation between testis diseases and the TRP family.</p>
Sujet(s)
Animaux , Mâle , Rats , ARN messager , Génétique , Métabolisme , Rat Sprague-Dawley , Canaux cationiques TRPM , Génétique , Métabolisme , Canaux cationiques TRPV , Génétique , Métabolisme , Testicule , MétabolismeRÉSUMÉ
<p><b>OBJECTIVE</b>To investigate the expression of transient receptor potential melastatin (TRPM) and transient receptor potential vanilloid (TRPV) channel family genes in rat spermatogenic cells.</p><p><b>METHODS</b>Rat spermatogenic cells were isolated by a mechanical procedure and the total RNA was extracted using TRIzol reagent. TRPM and TRPV channel family genes were amplified by RT-PCR and the presence of the target genes was detected by agarose gel electrophoresis. The relative gene expression levels were measured by real-time quantitative RT-PCR.</p><p><b>RESULTS</b>TRPV5, TRPM3, TRPM4 and TRPM7 mRNAs were expressed in rat spermatogenic cells, but TRPV1, TRPV2, TRPV3, TRPV4, TRPV6, TRPM1, TRPM2, TRPM5, TRPM6, TRPM7 and TRPM8 mRNAs were not detected. The relative expressions of TRPM and TRPV mRNA were determined by quantitative real-time RT-PCR. TRPM7 expression was the highest among all the TRPM subtypes in rat spermatogenic cells, at a level equivalent to (0.0430-/+0.0034)% of beta-actin expression. TRPM3 and TRPM4 were also highly expressed, but their expression levels were only approximately 56% and 63% of that of TRPM7, respectively. For the TRPV subfamily, only TRPV5 mRNA was abundantly expressed at the level of (0.0157-/+0.0029)% relative to that of beta-actin.</p><p><b>CONCLUSION</b>TRPV5, TRPM3, TRPM4 and TRPM7 mRNAs were coexpressed in spermatogenic cells in rats, among which TRPM4 and TRPM7 mRNA were expressed at high levels. TRPM4 and TRPM7 channels may be involved in the regulation of growth, differentiation and maturation of rat spermatogenic cells and are associated with the generation of the sperms.</p>
Sujet(s)
Animaux , Mâle , Rats , ARN messager , Génétique , Métabolisme , Rat Sprague-Dawley , Spermatocytes , Biologie cellulaire , Métabolisme , Spermatogonies , Biologie cellulaire , Métabolisme , Canaux cationiques TRPM , Génétique , Métabolisme , Canaux cationiques TRPV , Génétique , MétabolismeRÉSUMÉ
<p><b>OBJECTIVE</b>To investigate the best dose and the long-term effect of the human insulin-like growth factor-1 (hIGF-1) gene injection into the penis of aged rats.</p><p><b>METHODS</b>Included in this study were 10 young (4 months old) and 40 aged (24 months old) Sprague-Dawley male rats, the latter equally divided into a PBS control and a 10 microg, a 100 microg and a 1 000 microg hIGF-1 injection group. Electrical stimulation was conducted 4 and 8 weeks after hIGF-1 injection into the penile corpus cavernous of the rats to detect the intracavernous pressure (ICP) and mean arterial pressure (MAP). Dose - and time -associated therapeutic results were analyzed and the mRNA expression of hIGF-1 determined by RT - PCR.</p><p><b>RESULTS</b>ICP, MAP and total ICP were significant decreased by electrical stimulation in the aged rats as compared with the young ones (P < 0.05), statistically increased in the three hIGF-1 dose groups in comparison with the PBS controls (P < 0.05), and showed no obvious difference between the young rats and the latter two dose groups at 4 and 8 weeks. Although less obvious effect was achieved in the 10 microg group than in the young rats, the therapeutic result was still of significance. The mRNA expression of the hIGF-1 gene was confirmed in all the hIGF-1 treated rats.</p><p><b>CONCLUSION</b>The hIGF-1 therapy can improve erectile function in aged rats, 100 microg suffices for effective erection and the effect may last at least 8 weeks for a single dose.</p>
Sujet(s)
Animaux , Mâle , Rats , Vieillissement , Physiologie , Relation dose-effet des médicaments , Dysfonctionnement érectile , Thérapeutique , Thérapie génétique , Méthodes , Facteur de croissance IGF-I , Génétique , Physiologie , Pénis , Métabolisme , Plasmides , Génétique , ARN messager , Génétique , Métabolisme , Rat Sprague-Dawley , RT-PCR , Facteurs tempsRÉSUMÉ
<p><b>OBJECTIVE</b>To evaluate the incidence of capsular contracture in breast augmentation with textured versus smooth mammary Implants.</p><p><b>METHODS</b>Randomized controlled trials (RCTs) and clinical controlled trials (CCTs) were collected from Medline, Embase from May 1966 to May 2006, cochrane library (Issue 2, 2005), and CBM disc from May 1979 to May 2006. We handsearched Chinese Journal of Plastic Surgery (from establishment to May 2006) and Journal of Plastic and Reconstructive Surgery of America (from establishment to May 2006). RCTs were included. Data were extracted by two reviewers with designed extraction form RevMan. 4.2.8 software was used for data analysis.</p><p><b>RESULTS</b>Six RCTs were included. The combined results of meta analysis showed that patients with textured implants had a lower tendency to develop capsules contracture than those with smooth implants either at one year or ten years after the breast augmentation.</p><p><b>CONCLUSIONS</b>Compared with smooth mammary implants, textured surface implants significantly reduce the incidence of capsular contracture after breast augmentation.</p>
Sujet(s)
Femelle , Humains , Implants mammaires , Contracture , Médecine factuelle , Mammoplastie , Méthodes , Complications postopératoires , Essais contrôlés randomisés comme sujetRÉSUMÉ
<p><b>OBJECTIVE</b>A community survey was developed in order to analyses and assess the recognition of plastic surgery. And to provide some initial and useful evidence document for our other jobs.</p><p><b>METHODS</b>One thousand and one hundred individuals of various ages, either sex, different occupation and education levels, ethnically/racially diverse, social background, participated in this survey. All questionnaires were analyzed and chi-square analysis was performed for each question to compare the pattern of responses among the categories of respondents using the SPSS 11.5.</p><p><b>RESULTS</b>Nine hundred and forty six individuals completed the survey (overall response rate 86%). Group 1 consisted of 342 general college students; The second group consisted of 427 medical college students; the third included 129 general practitioners, and 48 members of the general public comprised the fourth group of respondents. The results reveal that the majority of the crowd in the four groups needs more information about the benefits that our specialty can offer them.</p><p><b>CONCLUSIONS</b>Despite the rapid progress that has occurred in the field of plastic surgery in the last 10 years, a large portion of the population is still unaware, even misunderstanding of the specialty. Therefore, they may not be taking advantage of the optimal care that is already available. And certainly, it also seriously hindrance the specialty. We should take effective methods to improve the advocacy from them. However, in our country, there is a scarcity of empirical evidence about the public perception of plastic surgery; this pilot study attempts to serve our jobs.</p>